Bio-Techne Corp. buy melinda
Start price
21.11.17
/
50%
€7.45
Target price
30.11.17
€7.61
Performance (%)
2.23%
End price
30.11.17
€7.62
Summary
This prediction ended on 30.11.17 with a price of €7.62. With a performance of 2.23%, the BUY prediction by melinda for Bio-Techne Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Bio-Techne Corp. | 4.861% | 4.861% | 2.027% | - |
iShares Core DAX® | 4.094% | 3.543% | 17.404% | 20.326% |
iShares Nasdaq 100 | 1.424% | 0.512% | 39.212% | 55.365% |
iShares Nikkei 225® | -1.572% | -4.633% | 15.731% | 2.146% |
iShares S&P 500 | 1.822% | 0.963% | 30.396% | 45.950% |
Comments by melinda for this prediction
In the thread Bio-Techne Corp. diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 30/11 Präsentation
Bio-Techne Corp. engagiert in der Entwicklung, Herstellung und Verkauf von Biotechnologie Reagenzien und Instrumente für die Forschung und markets.It klinische Diagnose ist in drei Segmente sind: Biotechnologie, Protein-Plattformen, und Diagnostics.
(Zielkurs erreicht)